Global pharmaceutical companies are aggressively searching for new medicines in China
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
...
Read moreDetailsHome » Eli Lilly to sign $2bn deal for AI drug development with Hong Kong biotech
Global pharmaceutical companies are aggressively searching for new medicines in China
...
Read moreDetails...
Read moreDetails...
Read moreDetails